20.06.21 CNS Tumours Flashcards
1
Q
What are CNS tumours
A
- Central nervous system tumours
- Involve brain and/or spinal cord.
- most common types= gliomas and meningiomas (combined= 70% of CNS tumours)
2
Q
How common are CNS tumours in children (<15 yrs)
A
- Second most common
- 25%
3
Q
Are CNS/ brain tumours sub grouped into benign/ malignant
A
-No as significant morbidity/mortality is due to growth and adverse effects of “space occupying lesions” of “benign” brain tumours.
4
Q
How are CNS tumours grouped
A
- Grade 1 and 2= slow growing, relatively contained, unlike to spread. Difficult to culture.
- Grade 3 and 4= fast growing, cannot be treated by surgery alone, need radio/chemotherapies
5
Q
Two main cell types in CNS
A
Neurons and glial cells
6
Q
What are the major glial types
A
- Astrocytes: control potassium levels in extracellular space, roles in CNS development
- oligodendrocytes: responsible for formation of myelin sheath around nerve fibres.
7
Q
Review of medulloblastoma
A
- Paediatric noninvasive, rapidly growing primary brain tumour. Can spread through cerebrospinal fluid, metastasising to other locations of brain.
- 30% cases die within 2 years.
- Survivors suffer long term side effects due to treatment.
- 17p loss and 17q gain are most frequent cytogenetic abnormalities. Isochromosome 17q seen in 30-50% tumours.
- Pathways disrupted= WNT (due to TNNB1 mutations), SHH (due to PTCH1, SMO, SUFU mutations), Photoreceptor/ GABAergic
8
Q
What are CNS gliomas
A
- Tumors involving glial cells.
- Account for >70% brain neoplasms
- e.g. oligodendroglioma and glioblastoma
9
Q
Review of oligodendroglioma
A
- Better prognosis and response to treatment than other glioma subtypes
- Loss of 1p and 19q seen in 80% cases. Predicts increased chemosensitivity and better prognosis. Helps confirm diagnosis.
- Detected by FISH or SNP array, PCR
10
Q
Review of glioblastoma
A
- Most common primary brain tumour (50% of all primary brain gliomas, 12-15% of all brain tumours)
- Usually seen in adults
- Very poor prognosis
- Common genetic findings: gain of 7p11.2 (EGFR- activates RAS pathway), 9p21.3 loss (CDKN2A- tumour suppressor), 10q23.31 (PTEN- tumour suppressor), inactivation of IDH1/2
11
Q
Which 3 genes are commonly hypermethylated in glioblastoma
A
- MGMT- associated with TP53 mutations, better survival rate, due to more sensitivity to alkylating drugs. Prognostic test for glioma.
- GATA6- associated with better survival rate
- CASP8- associated with worse outcome.